Abiopharma

Clinical trial NCT04609592 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2027-09-01 → 2027-05-01 3. primary completion date: 2026-07-01 → 2026-11-01 4. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT06517758: status: RECRUITING → ACTIVE_NOT_RECRUITING.

Clinical trial NCT05623189 updates: 1. completion date: 2025-04-30 → 2025-03-31 2. primary completion date: 2025-04-30 → 2025-03-31

Clinical trial NCT05635643: status: RECRUITING → ACTIVE_NOT_RECRUITING.

Clinical trial NCT07593391: start date: 2026-05-20 → 2026-06-08.

Clinical trial NCT01737242: completion date: 2027-12-31 → 2033-12-31.

Clinical trial NCT04838769: completion date: 2027-03-01 → 2026-12-01.

Clinical trial NCT02942290 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2027-01-01 → 2026-04-15 3. primary completion date: 2027-01-01 → 2026-04-15 4. enrollment: 129 → 134 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT04489719 updates: 1. completion date: 2029-08-01 → 2030-08-01 2. primary completion date: 2026-08-01 → 2027-08-01

Clinical trial NCT03203473: completion date: 2026-06-28 → 2026-12-28.

Clinical trial NCT05777993: enrollment: 6 → 59 participants.

Clinical trial NCT07734870: start date: 2026-08-23 → 2026-09-15.

Clinical trial NCT07613710 updates: 1. completion date: 2026-12-18 → 2027-02-16 2. primary completion date: 2026-12-01 → 2027-02-09

Clinical trial NCT07513285 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-08-19 → 2026-08-06

Clinical trial NCT06748053: primary completion date: 2026-07-17 → 2026-07-14.